SCHEMBL21733286

SCHEMBL21733286

N[C@@H]1CC[C@@H](c2nnc(C(F)F)o2)OC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21733288 1.00
SCHEMBL24311842 0.82
SCHEMBL21707308 0.77 KDM1A (0.33)
Hydrochloric Acid SCHEMBL21680681 0.76 KDM1A (0.33)
Hydrochloric Acid SCHEMBL21680678 0.76 KDM1A (0.33)
SCHEMBL24311430 0.72
SCHEMBL20796409 0.69
SCHEMBL13452967 0.69 GAA (0.30)
SCHEMBL20796399 0.68
SCHEMBL20772067 0.68 ATF4 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572362-B2 Pyrrolo[1,2-b]pyridazine derivatives GILEAD SCIENCES, INC. (US) 2023-02-07 US disclosed
US-20200071333-A1 PYRROLO[1,2-b]PYRIDAZINE DERIVATIVES GILEAD SCIENCES, INC. 2020-03-05 US disclosed
WO-2020036979-A1 PYRROLO[1,2-B]PYRIDAZINE DERIVATIVES AS IRAK4 INHIBITORS GILEAD SCIENCES, INC. (US) 2020-02-20 WO disclosed